Skip to main content
JAC-Antimicrobial Resistance logoLink to JAC-Antimicrobial Resistance
. 2023 Jan 12;5(1):dlad002. doi: 10.1093/jacamr/dlad002

Correction to: Real-life temocillin use in Greater Paris area, effectiveness and risk factors for failure in infections caused by ESBL-producing Enterobacterales: a multicentre retrospective study

PMCID: PMC9834973  PMID: 36644413

This is a correction to: Aurélien Dinh, Clara Duran, Simrandeep Singh, Chloé Tesmoingt, Laura Bouabdallah, Antoine Hamon, Marie Antignac, Clément Ourghanlian, Marie-Caroline Loustalot, Jean Baptiste Pain, Benjamin Wyplosz, Helga Junot, Alexandre Bleibtreu, Hugues Michelon, The Temocillin Greater Paris Study Group, Real-life temocillin use in Greater Paris area, effectiveness and risk factors for failure in infections caused by ESBL-producing Enterobacterales: a multicentre retrospective study, JAC-Antimicrobial Resistance, Volume 5, Issue 1, February 2023, dlac132, https://doi.org/10.1093/jacamr/dlac132>

In the originally published version of this manuscript, the following sentence was omitted from the Acknowledgement section: “The authors would like to thank Eumedica for their support.”

This error has now been corrected.


Articles from JAC-Antimicrobial Resistance are provided here courtesy of British Society for Antimicrobial Chemotherapy and Oxford University Press

RESOURCES